newsfilter
← Latest News
GlobeNewswire·

GBT Initiates Expanded Access Program for Voxelotor in Patients With Sickle Cell Disease in Brazil

SOUTH SAN FRANCISCO, Calif., July 14, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced the initiation of an expanded access program (EAP) for voxelotor in Brazil for the treatment of sickle cell disease (SCD)